High Court To Mull Whether Order Certifying National TPP Class Warrants Review

( March 16, 2026, 1:26 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court will consider during its March 20 conference a petition for a writ of certiorari filed by two drug companies that argue the Ninth Circuit U.S. Court of Appeals erred in certifying a national third-party payer (TPP) class of entities that paid for the diabetes drug Actos, the court announced in a March 16 docket entry....

Attached Documents

Related Sections